A new technology offers treatment for HIV infection through a single injection
A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for… read more.
A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for… read more.
Advances in cellular immunotherapy that spur genetically modified T cells to attack cancer cells have revolutionized the treatment of certain blood cancers. Six such CAR-T cell therapies are… read more.
In this first-of-its-kind study, researchers from University College London (UCL) combined multiple NHS datasets on national laboratory testing data, primary care consultations, hospitalisations and deaths to reveal the… read more.
Breakthrough COVID-19 infection is more prevalent among vaccinated cancer patients than in the general population, and the results are more dangerous, researchers reported on April 8, 2022 in… read more.
Throughout the pandemic the University of Huddersfield’s Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they’re an important part of… read more.
Even vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to new… read more.
New research being presented at this year’s European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that adults (aged 18 or older) with severe obesity generate… read more.
Investigators report that even though there was some increase in cases of low-severity adverse events after third-dose vaccination against SARS-CoV-2 infection with mRNA vaccines, such third-dose vaccination did… read more.
Promotional campaigns designed to increase vaccine uptake are often ineffective, according to a new study in eight European countries. Some initiatives which highlight the benefits of immunisation may… read more.
Researchers report that outpatients with recent SARS-CoV-2 infection treated with Covid-19 convalescent plasma within nine days of diagnosis have achieved a decreased the incidence of hospitalization when compared… read more.
It is ‘too early’ to consider using a fourth dose of mRNA COVID-19 vaccines in the general population, according to the European Medicines Agency (EMA) and the European… read more.
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. The… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.